Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
2.970
+0.080 (2.77%)
Nov 21, 2024, 2:06 PM EST - Market open
Vivos Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 14 | 15 | 9 | 52 | 104 | - | |
| Market Cap Growth | 116.33% | 61.00% | -82.13% | -50.41% | - | - | |
| Enterprise Value | 9 | 16 | 5 | 25 | 111 | - | |
| Last Close Price | 2.89 | 12.44 | 10.05 | 56.25 | 147.75 | - | |
| PS Ratio | 0.71 | 1.08 | 0.58 | 3.07 | 7.99 | - | |
| PB Ratio | 1.80 | 36.24 | 1.93 | 2.03 | 5.67 | - | |
| P/TBV Ratio | 2.80 | - | 5.59 | 2.32 | 7.47 | - | |
| EV/Sales Ratio | 0.62 | 1.16 | 0.34 | 1.45 | 8.51 | - | |
| Debt / Equity Ratio | 0.21 | 4.85 | 0.50 | 0.05 | 0.07 | -2.28 | |
| Asset Turnover | 1.14 | 1.13 | 0.68 | 0.57 | 0.79 | 1.45 | |
| Quick Ratio | 1.32 | 0.25 | 0.58 | 3.43 | 3.10 | 0.15 | |
| Current Ratio | 1.44 | 0.34 | 0.80 | 3.64 | 3.22 | 0.22 | |
| Return on Equity (ROE) | -325.98% | -521.22% | -157.19% | -92.31% | -143.62% | -556.20% | |
| Return on Assets (ROA) | -60.87% | -88.43% | -66.00% | -41.24% | -33.11% | -83.92% | |
| Return on Capital (ROIC) | -136.35% | -224.74% | -91.98% | -52.33% | -49.96% | -160.01% | |
| Earnings Yield | -91.26% | -91.20% | -257.76% | -39.18% | -11.55% | - | |
| FCF Yield | -94.88% | -85.93% | -221.72% | -35.02% | -5.56% | - | |
| Buyback Yield / Dilution | -210.69% | -32.46% | -8.39% | -65.00% | -4.36% | -6.78% | |
| Total Shareholder Return | -210.69% | -32.46% | -8.39% | -65.00% | -4.36% | -6.78% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.